GB Meka
Stocks to watch

DGX

Compare

QUEST DIAGNOSTICS INC · Healthcare

$234.51
▲ 1.1%Close 2026-09-30

Live intraday price

Compare with our price levels

T2248.29
T1240.13
E1204.38
E3189.94
SL183.77

Close 2026-09-30: $234.51 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 12.8% · 1 whale recently bought

1 month
▼ 2.4%
3 months
▲ 9.0%
1 year
▲ 26.4%
Analyst target
$247.73 +5.6%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$204.38 -12.8%
E2$200.13 -14.7%
E3$189.94 -19.0%
Targets
T1$240.13 2.4%
T2$248.29 5.9%
T3$260.63 11.1%
Stop-loss
SL$183.77 -21.6%
Whale cost ~$182.56 -22.2%

Risk : reward 1 : 3.5Moves ~$6.17 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●แนวโน้มระยะยาวเป็นขาขึ้น (เหนือ MA200 และ MA200 ชี้ขึ้น)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
! Risks (1)
  • ●เซียนขายออก/ลดสัดส่วน 2 ราย: Lee Ainslie (ขายหมด), Joel Greenblatt (ลด)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Davis J. E. · CEO · Director

2026-09-01 · 10,000 shares @ $242.72 · pre-planned sale (10b5-1)

$2M
Sell

PREVOZNIK MICHAEL E · Officer

2026-08-28 · 16,010 shares @ $242.88 · pre-planned sale (10b5-1)

$4M
Sell

PREVOZNIK MICHAEL E · Officer

2026-08-28 · 6,237 shares @ $243.63 · pre-planned sale (10b5-1)

$2M
Sell

PREVOZNIK MICHAEL E · Officer

2026-08-28 · 430 shares @ $244.51 · pre-planned sale (10b5-1)

$105,141
Sell

DELANEY MARK E · Officer

2026-07-28 · 1,600 shares @ $235.18 · pre-planned sale (10b5-1)

$376,288
Sell

KUPPUSAMY KARTHIK · Officer

2026-06-04 · 8,147 shares @ $200.00 · pre-planned sale (10b5-1)

$2M
Sell

Davis J. E. · CEO · Director

2026-06-01 · 10,000 shares @ $194.14 · pre-planned sale (10b5-1)

$2M
Sell

Doherty Catherine T. · Officer

2026-03-05 · 5,558 shares @ $206.21 · pre-planned sale (10b5-1)

$1M
Sell

PREVOZNIK MICHAEL E · Officer

2026-03-05 · 3,878 shares @ $206.21 · pre-planned sale (10b5-1)

$799,682
Sell

Plewman Patrick · Officer

2026-03-05 · 2,855 shares @ $206.21 · pre-planned sale (10b5-1)

$588,730
Sell

KUPPUSAMY KARTHIK · Officer

2026-03-04 · 2,628 shares @ $204.86

$538,372
Sell

Doherty Catherine T. · Officer

2026-03-03 · 632 shares @ $207.73 · pre-planned sale (10b5-1)

$131,285
Sell

PREVOZNIK MICHAEL E · Officer

2026-03-03 · 526 shares @ $207.73 · pre-planned sale (10b5-1)

$109,266
Sell

Plewman Patrick · Officer

2026-03-03 · 410 shares @ $207.73 · pre-planned sale (10b5-1)

$85,169
Sell

Davis J. E. · CEO · Director

2026-03-02 · 10,000 shares @ $212.52 · pre-planned sale (10b5-1)

$2M

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-23Beat +11%

Actual EPS $3.12 · est. $2.82 · Before open

▲ 8.6%

Day 1

+5.9%

Next 20 days

2026-04-21Beat +6%

Actual EPS $2.50 · est. $2.37 · Before open

▲ 4.4%

Day 1

-7.1%

Next 20 days

2026-02-10In line +3%

Actual EPS $2.42 · est. $2.36 · Before open

▲ 7.4%

Day 1

-2.3%

Next 20 days

2025-10-21In line +4%

Actual EPS $2.60 · est. $2.50 · Before open

▼ 3.0%

Day 1

+0.4%

Next 20 days

2025-07-22In line +2%

Actual EPS $2.62 · est. $2.57 · Before open

▲ 7.1%

Day 1

+2.6%

Next 20 days

2025-04-22In line +3%

Actual EPS $2.21 · est. $2.15 · Before open

▲ 6.8%

Day 1

+3.1%

Next 20 days

2025-01-30In line +2%

Actual EPS $2.23 · est. $2.18 · Before open

▲ 5.6%

Day 1

+5.3%

Next 20 days

2024-10-22In line +2%

Actual EPS $2.30 · est. $2.26 · Before open

▲ 6.9%

Day 1

+2.3%

Next 20 days

Listen to the earnings call or read the full report on DGX's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$26.1B
Next earnings2026-10-22
P/E (price to earnings)25.1
Forward P/E (on expected earnings)19.6
Revenue growth (YoY)+10.2%
Earnings growth (YoY)+15.0%
Net profit margin+9.2%
ROE+14.6%
Debt to equity (D/E)81%
Dividend yield1.46%
Analyst targets (high / low)$265.00 / $204.00
Number of analysts15
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Sideways → · Uptrend ↗
RSI46
MA50 / MA200$237.28 / $204.65
Distance from MA200+14.6%
MACDNegative
1-year high / low$248.84 / $168.97
vs. S&P 500 (6 months)+2.0%
Volume vs. average0.17×